Yelena Shames, MSA, ACNP-BC, CNRN, discusses when immune checkpoint inhibitor treatment should be paused because of laboratory abnormalities.
Yelena Shames, MSA, ACNP-BC, CNRN
Advertisement
Articles by Yelena Shames, MSA, ACNP-BC, CNRN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
National Cancer Institute Explores Ivermectin as a Potential Cancer Therapy
2
Dr. Nicholas Hornstein on ctDNA, Colorectal Cancer and Why Better Drugs Are Coming
3
FDA Approves Sacituzumab Govitecan-hziy for First-Line Triple-Negative Breast Cancer
4
GLP-1 Therapies May Reduce Cardiovascular Risks for Breast Cancer Survivors
5